Cargando…
Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR)
Some biological aspects of the new complex imidazolium bisimidazole tetrachloro iridate(III)-IRIM- the iridium(III) analogue of ICR, were considered. More in detail the conformational effects produced by IRIM on DNA and the cytotoxic properties of IRIM on some selected human cell lines were measured...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365222/ https://www.ncbi.nlm.nih.gov/pubmed/18475945 http://dx.doi.org/10.1155/MBD.2000.195 |
_version_ | 1782154116115464192 |
---|---|
author | Marcon, G. Casini, A. Mura, P. Messori, L. Bergamo, A. Orioli, P. |
author_facet | Marcon, G. Casini, A. Mura, P. Messori, L. Bergamo, A. Orioli, P. |
author_sort | Marcon, G. |
collection | PubMed |
description | Some biological aspects of the new complex imidazolium bisimidazole tetrachloro iridate(III)-IRIM- the iridium(III) analogue of ICR, were considered. More in detail the conformational effects produced by IRIM on DNA and the cytotoxic properties of IRIM on some selected human cell lines were measured. Dialysis experiments and DNA thermal denaturation studies are suggestive of poor binding of IRIM to DNA; formation of interstrand crosslinks is not observed. In any case CD measurements suggest that addition of increasing amounts of IRIM to calf thymus DNA results into significant spectral changes, that are diagnostic of a direct interaction with DNA. A number of experiments carried out on the A2780 human ovarian carcinoma, B16 murine melanoma, MCF7 and TS mammary adenocarcinoma tumor cell lines strongly point out that IRIM does not exhibit significant growth inhibition effects within the concentration range 10(-4)-10(-6) M. It is suggested that the lower biological effects of IRIM compared to ICR are a consequence of the larger kinetic inertness of the iridium(III) center with respect to ruthenium(III). |
format | Text |
id | pubmed-2365222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23652222008-05-12 Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) Marcon, G. Casini, A. Mura, P. Messori, L. Bergamo, A. Orioli, P. Met Based Drugs Research Article Some biological aspects of the new complex imidazolium bisimidazole tetrachloro iridate(III)-IRIM- the iridium(III) analogue of ICR, were considered. More in detail the conformational effects produced by IRIM on DNA and the cytotoxic properties of IRIM on some selected human cell lines were measured. Dialysis experiments and DNA thermal denaturation studies are suggestive of poor binding of IRIM to DNA; formation of interstrand crosslinks is not observed. In any case CD measurements suggest that addition of increasing amounts of IRIM to calf thymus DNA results into significant spectral changes, that are diagnostic of a direct interaction with DNA. A number of experiments carried out on the A2780 human ovarian carcinoma, B16 murine melanoma, MCF7 and TS mammary adenocarcinoma tumor cell lines strongly point out that IRIM does not exhibit significant growth inhibition effects within the concentration range 10(-4)-10(-6) M. It is suggested that the lower biological effects of IRIM compared to ICR are a consequence of the larger kinetic inertness of the iridium(III) center with respect to ruthenium(III). Hindawi Publishing Corporation 2000 /pmc/articles/PMC2365222/ /pubmed/18475945 http://dx.doi.org/10.1155/MBD.2000.195 Text en Copyright © 2000 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Marcon, G. Casini, A. Mura, P. Messori, L. Bergamo, A. Orioli, P. Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) |
title | Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) |
title_full | Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) |
title_fullStr | Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) |
title_full_unstemmed | Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) |
title_short | Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) |
title_sort | biological properties of irim, the iridium(iii) analogue of (imidazolium (bisimidazole) tetrachlororuthenate) (icr) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365222/ https://www.ncbi.nlm.nih.gov/pubmed/18475945 http://dx.doi.org/10.1155/MBD.2000.195 |
work_keys_str_mv | AT marcong biologicalpropertiesofirimtheiridiumiiianalogueofimidazoliumbisimidazoletetrachlororuthenateicr AT casinia biologicalpropertiesofirimtheiridiumiiianalogueofimidazoliumbisimidazoletetrachlororuthenateicr AT murap biologicalpropertiesofirimtheiridiumiiianalogueofimidazoliumbisimidazoletetrachlororuthenateicr AT messoril biologicalpropertiesofirimtheiridiumiiianalogueofimidazoliumbisimidazoletetrachlororuthenateicr AT bergamoa biologicalpropertiesofirimtheiridiumiiianalogueofimidazoliumbisimidazoletetrachlororuthenateicr AT oriolip biologicalpropertiesofirimtheiridiumiiianalogueofimidazoliumbisimidazoletetrachlororuthenateicr |